Former Sen. Ben Sasse, dying of cancer, reflects on family, faith and the future of America

Dying of Cancer, Ben Sasse Says 'Miracle Drug' Shrank Tumors and Caused Bloody Face

Former U.S. Senator Ben Sasse of Nebraska was diagnosed with terminal pancreatic cancer. He says a "miracle drug" caused tumors to shrink, extending his life.

Former Sen. Ben Sasse talks about dying, 'miracle drug' on '60 Minutes'

Here's what we know about daraxonrasib, a drug currently under review by the FDA.

What is Daraxonrasib? Ben Sasse hails "miracle drug" on shrinking tumors

Ben Sasse, who is diagnosed with pancreatic cancer, has credited a new "miracle drug" for shrinking his tumors over the last four months.

Former US Senator Ben Sasse Reveals 'Miracle Drug' Prolonging His Life

In an interview with CBS 60 Minutes over the weekend, former Senator Ben Sasse told to nation about a 'miracle drug' that has prolonged his life for months Sasse also goes in depth about what he thinks about politics in Congress and the Trump administration. Sasse's Opinion on the Current Day Congress 'The Senate needs to be less like Instagram. The Senate needs to be more deliberative. And that means less smack-down nonsense. One of the fundame…

Ben Sasse credits miracle drug for 'extended time' while having five cancers

Former Republican Nebraska Sen. Ben Sasse credited “providence, prayer, and a miracle drug” for how he is still alive as he is dying from pancreatic cancer that has metastasized to four other regions. Sasse, who left Washington early to become the president of the University of Florida, discussed his terminal diagnosis in a 60 Minutes interview on Sunday. Sasse was later diagnosed in December 2025 with Stage 4 pancreatic cancer and given a ticki…

Former Sen. Ben Sasse, dying of cancer, reflects on family, faith and the future of America

Former Sen. Ben Sasse, dying of cancer, is using the time he has as "an opportunity to talk about bigger stuff." He reflects on America's future, and the importance of faith, community and family.